Sign In
Section Navigation
Common Title028
Official Title Twelve-Month Study in HIV-1 Seropositive Retroviral-Naive Patients to Compare the Safety and Efficacy of Indinavir (MK-639) and Zidovudine (AZT) Administered Concomitantly to Indinavir (MK-639) Alone and Zidovudine (AZT) Alone
ClinicalTrials.gov NCT00002443
Categories Treatment-NaiveDual TherapyMonotherapy
Funding
IndustryMerck Sharp & Dohme Corp
References
  • Lewi DS, Suleiman JM, Uip DE, et al. Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive HIV-infected individuals with CD4 cell counts between 50 and 250/mm3. Rev Inst Med Trop Sao Paulo. 2000;42:27-36.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.